Position in SUPN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,678,998
+$4,384,851 QoQ
Shares Held
100,602
+1534.5% QoQ
Ownership
0.173%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#64
of 331 holders
Holding Since
Sep 2021
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Jump Financial, LLC holds $51,184,372 across 18 Drug Manufacturers - Specialty & Generic names. SUPN ranks #4 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
247,196 | $17,763,504 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
|
238,753 | $8,277,566 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
569,956 | $5,699,560 | |
| 4 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
100,602 | $4,678,998 | |
| 5 | BHC |
Bausch Health Companies Inc.
|
611,100 | $3,012,723 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
70,430 | $2,889,742 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
42,773 | $1,548,382 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
104,200 | $1,509,858 |
All Filings in SUPN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,678,998 | 100,602 | Shares | Defined | 2026-08-13 | |
| 2025-09-30 | $294,147 | 6,155 | Shares | Defined | 2025-11-13 | |
| 2024-06-30 | $903,347 | 33,770 | Shares | Defined | 2024-11-14 | |
| 2023-06-30 | $850,698 | 28,300 | Shares | Sole | 2024-10-21 | |
| 2021-09-30 | $342,389 | 12,838 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||